Literature DB >> 2909755

Distribution and activity of antineoplastic drugs in a tumor model.

R E Durand1.   

Abstract

Antineoplastic drugs can be effective in solid tumors only if they can penetrate several cell layers and retain their activity in the tumor microenvironment. The capacity of several common chemotherapeutic agents to meet these requirements was evaluated in an in vitro tumor model, V79 Chinese hamster cells grown as spheroids. The delivery and toxicity of radioactively labeled 5-fluorouracil, lomustine, tetraplatin, and chlorambucil were determined by use of cell-sorting techniques to select cells as a function of their position (depth) within these spheroids, and the delivery and toxicity of doxorubicin (DOX) were evaluated on the basis of fluorescence intensity. Simultaneous measurement of drug level and toxicity in cells at the time of recovery from different depths within the spheroids led to the conclusion that drug delivery was a problem only for DOX. In contrast, several of the other agents showed a dissociation between cellular drug levels and activity, implicating a major role of the cellular microenvironment in modulating drug toxicity.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2909755     DOI: 10.1093/jnci/81.2.146

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


  19 in total

1.  Schedule-dependent potentiation of chemotherapy drugs by the hypoxia-activated prodrug SN30000.

Authors:  Xinjian Mao; Sarah McManaway; Jagdish K Jaiswal; Cho R Hong; William R Wilson; Kevin O Hicks
Journal:  Cancer Biol Ther       Date:  2019-05-26       Impact factor: 4.742

2.  Lack of in vitro-in vivo correlation of a novel investigational anticancer agent, SH 30.

Authors:  Srinivasu Poondru; Ralph E Parchment; Vivek Purohit; Patricia LoRusso; Jerome P Horwitz; Stuart T Hazeldine; Lisa Polin; Thomas Corbett; Bhaskara R Jasti
Journal:  Invest New Drugs       Date:  2002-02       Impact factor: 3.850

3.  Time- and concentration-dependent penetration of doxorubicin in prostate tumors.

Authors:  J H Zheng; C T Chen; J L Au; M G Wientjes
Journal:  AAPS PharmSci       Date:  2001

Review 4.  Drug and radiation resistance in spheroids: cell contact and kinetics.

Authors:  P L Olive; R E Durand
Journal:  Cancer Metastasis Rev       Date:  1994-06       Impact factor: 9.264

5.  Multicellular membranes as an in vitro model for extravascular diffusion in tumours.

Authors:  D S Cowan; K O Hicks; W R Wilson
Journal:  Br J Cancer Suppl       Date:  1996-07

6.  Relations between the penetration, binding and average concentration of cytostatic drugs in human tumour spheroids.

Authors:  M Erlanson; E Daniel-Szolgay; J Carlsson
Journal:  Cancer Chemother Pharmacol       Date:  1992       Impact factor: 3.333

7.  Slow penetration of anthracyclines into spheroids and tumors: a therapeutic advantage?

Authors:  R E Durand
Journal:  Cancer Chemother Pharmacol       Date:  1990       Impact factor: 3.333

8.  Discovery of a selective inhibitor of oncogenic B-Raf kinase with potent antimelanoma activity.

Authors:  James Tsai; John T Lee; Weiru Wang; Jiazhong Zhang; Hanna Cho; Shumeye Mamo; Ryan Bremer; Sam Gillette; Jun Kong; Nikolas K Haass; Katrin Sproesser; Ling Li; Keiran S M Smalley; Daniel Fong; Yong-Liang Zhu; Adhirai Marimuthu; Hoa Nguyen; Billy Lam; Jennifer Liu; Ivana Cheung; Julie Rice; Yoshihisa Suzuki; Catherine Luu; Calvin Settachatgul; Rafe Shellooe; John Cantwell; Sung-Hou Kim; Joseph Schlessinger; Kam Y J Zhang; Brian L West; Ben Powell; Gaston Habets; Chao Zhang; Prabha N Ibrahim; Peter Hirth; Dean R Artis; Meenhard Herlyn; Gideon Bollag
Journal:  Proc Natl Acad Sci U S A       Date:  2008-02-19       Impact factor: 11.205

9.  Expression of verapamil hypersensitivity in multidrug-resistant cells grown as multicellular spheroids.

Authors:  M Anderson; J R Warr
Journal:  Cancer Chemother Pharmacol       Date:  1990       Impact factor: 3.333

10.  E-cadherin increasing multidrug resistance protein 1 via hypoxia-inducible factor-1α contributes to multicellular resistance in colorectal cancer.

Authors:  Xi Liang; Xueqing Xu; Fengchao Wang; Ni Li; Jianming He
Journal:  Tumour Biol       Date:  2015-07-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.